Abnormal release of cardiac biomarkers in the presence of myocardial oedema evaluated by cardiac magnetic resonance after uncomplicated revascularization procedures

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorRIBAS, Fernando Faglioni
dc.contributor.authorHUEB, Whady
dc.contributor.authorREZENDE, Paulo Cury
dc.contributor.authorROCHITTE, Carlos Eduardo
dc.contributor.authorNOMURA, Cesar Higa
dc.contributor.authorVILLA, Alexandre Volney
dc.contributor.authorMORAIS, Thamara Carvalho
dc.contributor.authorLIMA, Eduardo Gomes
dc.contributor.authorBOROS, Gustavo Andre Boeing
dc.contributor.authorRIBEIRO, Matheus de Oliveira Laterza
dc.contributor.authorLINHARES-FILHO, Jaime Paula Pessoa
dc.contributor.authorDALLAZEN, Anderson Roberto
dc.contributor.authorSILVA, Rafael Rocha Mol
dc.contributor.authorRAMIRES, Jose Antonio Franchini
dc.contributor.authorKALIL-FILHO, Roberto
dc.date.accessioned2024-02-15T14:40:12Z
dc.date.available2024-02-15T14:40:12Z
dc.date.issued2023
dc.description.abstractAims To analyse the association of myocardial oedema (ME), observed as high T2 signal intensity (HT2) in cardiac magnetic resonance imaging, with the release of cardiac biomarkers, ventricular ejection, and clinical outcomes after revascularization. Methods and results Patients with stable coronary artery disease with the indication for revascularization were included. Biomarker levels [troponin I (cTnI) and creatine kinase MB (CK-MB)] and T2-weighted and late gadolinium enhancement (LGE) images were obtained before and after the percutaneous or surgical revascularization procedures. The association of HT2 with the levels of biomarkers, with and without LGE, evolution of left ventricular ejection fraction (LVEF), and 5-year clinical outcomes were assessed. A total of 196 patients were divided into 2 groups: Group 1 (HT2, 40) and Group 2 (no HT2, 156). Both peak cTnI (8.9 and 1.6 ng/mL) and peak CK-MB values (44.7 and 12.1 ng/mL) were significantly higher in Group 1. Based on the presence of new LGE, patients were stratified into Groups A (no HT2/LGE, 149), B (HT2, 9), C (LGE, 7), and D (both HT2/LGE, 31). The peak cTnI and CK-MB values were 1.5 and 12.0, 5.4 and 44.7, 5.0 and 18.3, and 9.8 and 42.8 ng/mL in Groups A, B, C, and D, respectively, and were significantly different. The average LVEF decreased by 4.4% in Group 1 and increased by 2.2% in Group 2 (P = 0.057). Conclusion ME after revascularization procedures was associated with increased release of cardiac necrosis biomarkers, and a trend towards a difference in LVEF, indicating a role of ME in cardiac injury after interventions.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.identifier.citationEUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, v.24, n.12, p.1700-1709, 2023
dc.identifier.doi10.1093/ehjci/jead171
dc.identifier.eissn2047-2412
dc.identifier.issn2047-2404
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/57884
dc.language.isoeng
dc.publisherOXFORD UNIV PRESSeng
dc.relation.ispartofEuropean Heart Journal-Cardiovascular Imaging
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright OXFORD UNIV PRESSeng
dc.subjectmyocardial oedemaeng
dc.subjecthigh T2 signal intensityeng
dc.subjectcardiac MRIeng
dc.subjectrevascularizationeng
dc.subjectbiomarkerseng
dc.subjectperiprocedural injuryeng
dc.subject.otherinfarctioneng
dc.subject.otherriskeng
dc.subject.otherischemiaeng
dc.subject.othersurgeryeng
dc.subject.wosCardiac & Cardiovascular Systemseng
dc.subject.wosRadiology, Nuclear Medicine & Medical Imagingeng
dc.titleAbnormal release of cardiac biomarkers in the presence of myocardial oedema evaluated by cardiac magnetic resonance after uncomplicated revascularization procedureseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalVILLA, Alexandre Volney:Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Div Clin Inst Coracao InCor, Rua Dr Eneas de Carvalho Aguiar 44,AB Floor,Room 1, BR-05403000 Sao Paulo, SP, Brazil
hcfmusp.author.externalLINHARES-FILHO, Jaime Paula Pessoa:Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Div Clin Inst Coracao InCor, Rua Dr Eneas de Carvalho Aguiar 44,AB Floor,Room 1, BR-05403000 Sao Paulo, SP, Brazil
hcfmusp.citation.scopus1
hcfmusp.contributor.author-fmusphcFERNANDO FAGLIONI RIBAS
hcfmusp.contributor.author-fmusphcWHADY ARMINDO HUEB
hcfmusp.contributor.author-fmusphcPAULO CURY REZENDE
hcfmusp.contributor.author-fmusphcCARLOS EDUARDO ROCHITTE
hcfmusp.contributor.author-fmusphcCESAR HIGA NOMURA
hcfmusp.contributor.author-fmusphcTHAMARA CARVALHO MORAIS
hcfmusp.contributor.author-fmusphcEDUARDO GOMES LIMA
hcfmusp.contributor.author-fmusphcGUSTAVO ANDRE BOEING BOROS
hcfmusp.contributor.author-fmusphcMATHEUS DE OLIVEIRA LATERZA RIBEIRO
hcfmusp.contributor.author-fmusphcANDERSON ROBERTO DALLAZEN
hcfmusp.contributor.author-fmusphcRAFAEL ROCHA MOL SILVA
hcfmusp.contributor.author-fmusphcJOSE ANTONIO FRANCHINI RAMIRES
hcfmusp.contributor.author-fmusphcROBERTO KALIL FILHO
hcfmusp.description.beginpage1700
hcfmusp.description.endpage1709
hcfmusp.description.issue12
hcfmusp.description.volume24
hcfmusp.origemWOS
hcfmusp.origem.pubmed37453130
hcfmusp.origem.scopus2-s2.0-85178494852
hcfmusp.origem.wosWOS:001032502500001
hcfmusp.publisher.cityOXFORDeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAbdel-Aty H, 2009, JACC-CARDIOVASC IMAG, V2, P832, DOI 10.1016/j.jcmg.2009.04.007eng
hcfmusp.relation.referenceBijnens B, 2008, HEART, V94, P1117, DOI 10.1136/hrt.2007.135392eng
hcfmusp.relation.referenceEitel I, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-13eng
hcfmusp.relation.referenceFernández-Jiménez R, 2015, J AM COLL CARDIOL, V65, P315, DOI 10.1016/j.jacc.2014.11.004eng
hcfmusp.relation.referenceFriedrich MG, 2010, NAT REV CARDIOL, V7, P292, DOI 10.1038/nrcardio.2010.28eng
hcfmusp.relation.referenceGARCIADORADO D, 1993, CARDIOVASC RES, V27, P1462, DOI 10.1093/cvr/27.8.1462eng
hcfmusp.relation.referenceHerrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455eng
hcfmusp.relation.referenceHirleman E, 2008, PERFUSION-UK, V23, P311, DOI 10.1177/0267659109105079eng
hcfmusp.relation.referenceHueb W, 2016, ANN THORAC SURG, V101, P2202, DOI 10.1016/j.athoracsur.2015.11.034eng
hcfmusp.relation.referenceLevy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-Xeng
hcfmusp.relation.referenceMcAlindon E, 2015, EUR HEART J-CARD IMG, V16, P738, DOI 10.1093/ehjci/jev001eng
hcfmusp.relation.referencePatel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001eng
hcfmusp.relation.referenceRahimi K, 2009, HEART, V95, P1937, DOI 10.1136/hrt.2009.173302eng
hcfmusp.relation.referenceRaman SV, 2010, J AM COLL CARDIOL, V55, P2480, DOI 10.1016/j.jacc.2010.01.047eng
hcfmusp.relation.referenceTSCHOLAKOFF D, 1986, RADIOLOGY, V159, P667, DOI 10.1148/radiology.159.3.3704148eng
hcfmusp.relation.referenceWhite HD, 2011, J AM COLL CARDIOL, V57, P2406, DOI 10.1016/j.jacc.2011.01.029eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationc194b219-c3b4-4198-8c01-6968d16371a6
relation.isAuthorOfPublication60b53bfd-695d-4a77-a444-de58fb0bada0
relation.isAuthorOfPublication88850f7d-56cd-4ba5-b2d4-b824b64b15c4
relation.isAuthorOfPublicatione2e8fbd4-e06d-4a3f-a0e9-76a4650e56f2
relation.isAuthorOfPublication1fef1cbe-6c9d-4299-8b66-5a1c7cbf8b1b
relation.isAuthorOfPublication5b5a98b6-17c0-4626-92b0-eb6ef18d5d2c
relation.isAuthorOfPublicationa354095f-ee4d-48b4-8684-c6cdfa32b731
relation.isAuthorOfPublicationcf6f251d-c8d6-4fc5-b5f6-8a4e4c32612e
relation.isAuthorOfPublication387f5749-2dec-472b-a099-73ba583adfb7
relation.isAuthorOfPublication2381f6f9-9b58-46ba-b851-f78b82d2d9a9
relation.isAuthorOfPublication9b94d20b-332a-4039-b4b8-f5a77cafe16f
relation.isAuthorOfPublicationf5d62c04-a7ad-4984-95b7-4b603eceb3da
relation.isAuthorOfPublicationc934e4bf-7bb3-4e4d-aaac-07d8be41a3ac
relation.isAuthorOfPublication.latestForDiscoveryc194b219-c3b4-4198-8c01-6968d16371a6
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_RIBAS_Abnormal_release_of_cardiac_biomarkers_in_the_presence_2023.PDF
Tamanho:
729.29 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/44
Artigos e Materiais de Revistas Científicas - LIM/64
Artigos e Materiais de Revistas Científicas - LIM/65
Carregar mais